Association between remnant cholesterol, metabolic syndrome, and cardiovascular disease: post hoc analysis of a prospective national cohort study

被引:0
作者
Junguo Jin
Xiangming Hu
Melissa Francois
Ping Zeng
Weimian Wang
Bingyan Yu
Yingling Zhou
Haojian Dong
机构
[1] Southern Medical University,Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences)
[2] SUNY Upstate Medical University,College of Medicine
[3] Southern Medical University,The Second School of Clinical Medicine
[4] South China University of Technology,School of Medicine
[5] Nyingchi People’s Hospital,undefined
来源
European Journal of Medical Research | / 28卷
关键词
Remnant cholesterol; Metabolic syndrome; Inflammation; Insulin resistance; Cardiovascular disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 194 条
[1]  
Mottillo S(2010)The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis J Am Coll Cardiol 56 1113-1132
[2]  
Filion KB(2018)The global epidemic of the metabolic syndrome Curr Hypertens Rep 20 12-1131
[3]  
Genest J(2022)Metabolic syndrome: updates on pathophysiology and management in 2021 Int J Mol Sci 23 786-771
[4]  
Joseph L(2017)Antiinflammatory therapy with canakinumab for atherosclerotic disease N Engl J Med 377 1119-302
[5]  
Pilote L(2021)The aetiology and molecular landscape of insulin resistance Nat Rev Mol Cell Biol 22 751-635
[6]  
Poirier P(2014)Insulin resistance and hyperglycaemia in cardiovascular disease development Nat Rev Endocrinol 10 293-4332
[7]  
Saklayen MG(2014)Triglycerides and cardiovascular disease Lancet 384 626-122
[8]  
Fahed G(2021)Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study Eur Heart J 42 4324-367
[9]  
Aoun L(2019)Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies Cardiovasc Diabetol 18 48-1275
[10]  
Bou Zerdan M(2011)Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk Curr Opin Lipidol 22 113-1309